Total Payments
$5,826
2024 Payments
$677.00
Companies
40
Transactions
341
Medicare Patients
1,227
Medicare Billing
$200,717
Payment Breakdown by Category
Food & Beverage$5,639 (96.8%)
Education$186.73 (3.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,639 | 334 | 96.8% |
| Education | $186.73 | 7 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $910.24 | 44 | $0 (2022) |
| Novo Nordisk Inc | $862.38 | 64 | $0 (2024) |
| ABBVIE INC. | $484.13 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $390.68 | 29 | $0 (2024) |
| Lilly USA, LLC | $378.84 | 24 | $0 (2024) |
| Astellas Pharma US Inc | $330.32 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $271.30 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $238.45 | 16 | $0 (2020) |
| Amgen Inc. | $193.71 | 10 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $172.07 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $677.00 | 29 | Astellas Pharma US Inc ($202.29) |
| 2023 | $139.19 | 8 | Novo Nordisk Inc ($43.15) |
| 2022 | $103.73 | 5 | ABBVIE INC. ($54.30) |
| 2021 | $817.33 | 51 | AbbVie Inc. ($189.08) |
| 2020 | $1,517 | 92 | ViiV Healthcare Company ($254.30) |
| 2019 | $1,745 | 99 | ViiV Healthcare Company ($486.04) |
| 2018 | $755.53 | 52 | Novo Nordisk Inc ($211.77) |
| 2017 | $71.04 | 5 | SANOFI-AVENTIS U.S. LLC ($16.10) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 14 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.41 | General |
| 03/07/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: DIABETES | ||||||
| 02/27/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $42.66 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/21/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/16/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: Diabetes | ||||||
| 02/08/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Diabetes | ||||||
| 02/07/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: Diabetes | ||||||
| 02/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DIABETES | ||||||
| 01/23/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/02/2018 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 12/15/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug), ONZETRA Xsail | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/12/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: DIABETES | ||||||
| 11/30/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Respiratory | ||||||
| 11/29/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 36 | $5,040 | $3,312 |
| 2021 | 5 | 411 | 763 | $152,895 | $61,736 |
| 2020 | 11 | 801 | 1,723 | $356,166 | $135,669 |
Total Patients
1,227
Total Services
2,522
Medicare Billing
$200,717
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 36 | $5,040 | $3,312 | 65.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 208 | 467 | $102,740 | $39,365 | 38.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 189 | $28,350 | $11,158 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 67 | 67 | $16,080 | $9,046 | 56.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $5,100 | $1,708 | 33.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 25 | 25 | $625.00 | $458.88 | 73.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 326 | 1,087 | $239,140 | $87,777 | 36.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 138 | 278 | $41,700 | $15,370 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 107 | 107 | $25,680 | $12,778 | 49.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 52 | 52 | $17,680 | $5,045 | 28.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 44 | 56 | $9,235 | $4,476 | 48.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 22 | $9,130 | $3,693 | 40.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 12 | 12 | $5,700 | $2,421 | 42.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 63 | 63 | $1,575 | $1,195 | 75.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 18 | $2,490 | $1,085 | 43.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 13 | 13 | $1,586 | $986.66 | 62.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 15 | $2,250 | $842.44 | 37.4% |
About Dr. Louis Crevecoeur, MD
Dr. Louis Crevecoeur, MD is a Internal Medicine healthcare provider based in Seaford, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1609127893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Louis Crevecoeur, MD has received a total of $5,826 in payments from pharmaceutical and medical device companies, with $677.00 received in 2024. These payments were reported across 341 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,639).
As a Medicare-enrolled provider, Crevecoeur has provided services to 1,227 Medicare beneficiaries, totaling 2,522 services with total Medicare billing of $200,717. Data is available for 3 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Seaford, DE
- Active Since 09/27/2012
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609127893
Products in Payments
- DOVATO (Drug) $709.13
- Ozempic (Drug) $463.71
- TRULICITY (Drug) $304.61
- XARELTO (Drug) $209.25
- Tresiba (Drug) $143.10
- Mavyret (Drug) $136.46
- CUBICIN RF (Drug) $125.53
- JULUCA (Drug) $118.93
- Livalo (Drug) $114.40
- STIOLTO RESPIMAT (Drug) $111.57
- JANUVIA (Drug) $107.34
- VRAYLAR (Drug) $106.40
- Vascepa (Drug) $97.83
- Aimovig (Biological) $97.81
- TRADJENTA (Drug) $97.40
- TRIUMEQ (Drug) $82.18
- CHANTIX (Drug) $76.56
- DALVANCE (Drug) $75.34
- Arikayce (Drug) $75.00
- MYRBETRIQ (Drug) $69.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Seaford
Dr. Jeffrey Elfenbein, D.o, D.O
Internal Medicine — Payments: $27,890
Internal Medicine $27,890
Dr. Mark Evangelista, M.d, M.D
Internal Medicine — Payments: $13,519
Internal Medicine $13,519
Dr. Richard Simons, D.o, D.O
Internal Medicine — Payments: $7,910
Internal Medicine $7,910
Dr. Angel Alicea, M.d, M.D
Internal Medicine — Payments: $7,728
Internal Medicine $7,728
Alvaro Buenano, M.d, M.D
Internal Medicine — Payments: $5,198
Internal Medicine $5,198
Dr. Ronald Luna, Md, MD
Internal Medicine — Payments: $3,522
Internal Medicine $3,522